0001127602-24-026591.txt : 20241106 0001127602-24-026591.hdr.sgml : 20241106 20241106162934 ACCESSION NUMBER: 0001127602-24-026591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241101 FILED AS OF DATE: 20241106 DATE AS OF CHANGE: 20241106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coen Steven P. CENTRAL INDEX KEY: 0001977441 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40097 FILM NUMBER: 241431490 MAIL ADDRESS: STREET 1: C/O GINKGO BIOWORKS HOLDINGS, INC. STREET 2: 27 DRYDOCK AVENUE, 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc. CENTRAL INDEX KEY: 0001830214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 872652913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (877) 442-5362 MAIL ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp. DATE OF NAME CHANGE: 20210210 FORMER COMPANY: FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp. DATE OF NAME CHANGE: 20201027 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-11-01 0001830214 Ginkgo Bioworks Holdings, Inc. DNA 0001977441 Coen Steven P. C/O GINKGO BIOWORKS HOLDINGS, INC. 27 DRYDOCK AVENUE BOSTON MA 02210 1 See remarks 0 Class A Common Stock 2024-11-01 4 M 0 587 A 6633 D Class A Common Stock 2024-11-01 4 M 0 156 A 6789 D Class A Common Stock 2024-11-04 4 S 0 333 7.576 D 6456 D Restricted Stock Units 2024-11-01 4 M 0 587 D Class A Common Stock 587 17623 D Restricted Stock Units 2024-11-01 4 M 0 156 D Class A Common Stock 156 6251 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Chief Accounting Officer /s/ Karen Tepichin, Attorney-in-Fact 2024-11-06